Arcturus Therapeutics

Arcturus Therapeutics News & Events

SEC Filings

Filing date Description Form Filing Group Issuer View

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Arcturus Therapeutics Ltd. EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

CT ORDER

CT ORDER
Other
Arcturus Therapeutics Ltd. View HTML

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

424B5
Registration Statements
Arcturus Therapeutics Ltd. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Arcturus Therapeutics Ltd. View HTML

Securities offered to employees pursuant to employee benefit plans

S-8
Registration Statements
Arcturus Therapeutics Ltd. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Arcturus Therapeutics Ltd. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Arcturus Therapeutics Ltd. EX-101.INS - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Arcturus Therapeutics Ltd. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Arcturus Therapeutics Ltd. View HTML

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act

6-K
Current Reports
Arcturus Therapeutics Ltd. View HTML

Copyright Morningstar